|12-06-2018 10:55 PM CET - Health & Medicine||
Crohn's Disease Diagnostic and Therapeutic Market: Segmented by Applications and Geography Trends, Growth and Forecasts 2023
Press release from: Industry Research
The Crohn's Disease Diagnostic and Therapeutic Market Report assists the Industry experts, analysts and business decision makers to isolate the current market scenario, opportunities, upcoming market trends and pricing analysis. The Crohn's Disease Diagnostic and Therapeutic Market report provides crucial information about the market, including Opinions from Industry experts, and the recent progressions and developments of the Crohn's Disease Diagnostic and Therapeutic industry.
The Crohn's Disease Diagnostic and Therapeutic market report gives Analysis of incomes, limits and benefits of Key Manufacturers including the market holdings, offers of units, income dispersion, and the measures that have been taken to overcome the issues faced.
Overview of Crohn's Disease Diagnostic and Therapeutic Market:
The global Crohn's disease diagnostic and therapeutic market is estimated to grow at a good CAGR during the forecast period. Crohn’s disease (CD) is an inflammatory bowel disease (IBD) that can affect any part of the gastrointestinal tract from mouth to the anus. It is caused by a combination of environmental, immune, and bacterial factors, in genetically predisposed individuals.
Affected Population Increasing with Time
It is estimated that around 1.6 million Americans have the inflammatory bowel disease (IBD). This number includes about 780,000 population are having Crohn’s disease, and another 907,000 people are with ulcerative colitis. Research suggests that about six to 15 new cases of Crohn's disease are diagnosed per 100,000 people each year. People are most frequently diagnosed with Crohn's disease and ulcerative colitis in the late adolescence or in early adulthood, even though the diagnosis may happen at any age. Many population-based research studies have shown that Crohn's disease is somewhat more common in women than men, while ulcerative colitis is slightly more common in men than women. As the prevalence of the disease increases, it is expected to drive the Crohn's disease diagnostic and therapeutic market.
Also, the increasing demand for prompt diagnosis and multiple symptoms associated with the disease requiring individual therapeutic attention, are increasing the growth of the market.
Request Sample Copy of Report @ www.industryresearch.biz/enquiry/request-sample/13103180
Lack of a Cost-effective Treatment
Current costs for the treatment and diagnosis of Crohn's disease is high, due to the availability of several new therapeutic drugs and changes in the surgical treatment of the disease. For example, the total cost of Crohn's disease in the United States is around USD 3.6 billion every year, and the average yearly medical cost per patient is about USD 8,265, with more than one-third of that cost being medications. Biologic medications or drugs are usually expensive. Hospitalization accounted for 31.4% of the cost. On an average, people who have to be hospitalized for Crohn’s disease are expected to spend about 5.8 days in the hospital. All these treatment cost issues are hindering the Crohn's diagnostic and therapeutic market. Also, as no specific treatment or drug is available in the market, and there is lack of awareness among the people coupled with symptom similarity with other gastrointestinal disease are hindering the market growth.
North America to Lead the Market
North America is dominating the Crohn's disease diagnostic and therapeutic market due to the increasing prevalence of Crohn's disease in the region. Asia-Pacific is expected to record a substantial growth in the forecast period.
Top Crohn's Disease Diagnostic and Therapeutic Manufacturers Covered in this report:
Janssen Biotech Inc.
Inc. (Valeant Pharmaceuticals)
Takeda's Pharmaceutical Ltd
and Johnson & Johnson
Significance of Crohn's Disease Diagnostic and Therapeutic Market report:
Know more about Crohn's Disease Diagnostic and Therapeutic industry plans that are now being comprised by major manufacturers in the market.
The assessed growth rate of Crohn's Disease Diagnostic and Therapeutic by size & share on the forecast period 2018-2023.
The unique aspects anticipated to induce Crohn's Disease Diagnostic and Therapeutic market for its forecasted period of 2023.
To understand the Crohn's Disease Diagnostic and Therapeutic industry scenario and its prospects.
Strategies of leading Crohn's Disease Diagnostic and Therapeutic Industry players for evolving the plans for success in today’s competitive market.
Reasons to Purchase the Report:
Follow the current and future global Crohn's disease diagnostic and therapeutic market in the developed and emerging markets.
Analyzing various perspectives of the market with the help of Porter’s
Five Forces Analysis.
Identify the segment that is expected to dominate the market.
Identify the regions that are expected to witness the fastest growth during the forecast period.
Identify the latest developments, market shares, and strategies employed by the major market players.
3-month analyst support along with the Market Estimate sheet (in Excel).
Price of Report: $ 4250 (Single User License)
Purchase Report @ www.industryresearch.biz/purchase/13103180
In the end the Crohn's Disease Diagnostic and Therapeutic Market report presents all the necessary data required to form resulting yielding business strategies for Industry experts, analysts and business decision makers to decide their business strategies and achieve proposed business aims.
Industry Researc.biz is the credible source for gaining the market research reports that will exponentially accelerate your business. We are among the leading report resellers in the business world committed towards optimizing your business. The reports we provide are based on a research that covers a magnitude of factors such as technological evolution, economic shifts and a detailed study of market segments.
3rd Floor, Silver Spring, Sahyadri farm
Opp Prabhavee Tech Park,
Baner - Mhalunge Road, Baner, Pune 411045.
This release was published on openPR.
News-ID: 1423400 • Views: 354More releases